NKG2D ligands in inflammatory joint diseases: analysis in human samples and mouse models.
Journal
Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521
Informations de publication
Date de publication:
Historique:
received:
22
04
2020
accepted:
31
08
2020
pubmed:
12
1
2021
medline:
3
9
2021
entrez:
11
1
2021
Statut:
ppublish
Résumé
NKG2D ligands (NKG2DLs) are stress-inducible molecules involved in multiple inflammatory settings. In this work, we quantified MICA, an NKG2DL, in the synovial fluid of patients suffering various arthritides and measured Nkg2dLs gene expression in murine models of acute joint inflammation. Soluble MICA (sMICA) was quantified by ELISA is synovial fluids harvested from patients suffering osteoarthritis, rheumatoid arthritis, psoriatic arthritis, calcium pyrophosphate crystal arthritis, urate crystal arthritis and reactive arthritis. Transcripts encoding murine NKG2DLs were quantified by RT-qPCR in the joints of mouse models of rheumatoid arthritis, urate crystal arthritis and osteoarthritis. Marked overproduction of sMICA was observed in the synovial fluid of RA patients. Mouse studies highlighted the complex transcriptional regulation of Nkg2d ligands encoding genes depending on the inflammatory setting and microenvironment CONCLUSIONS: sMICA quantification could be an interesting biomarker to identify acute inflammation in RA patients in whom classical markers (i.e. anti-citrullinated protein antibodies, ACPA) are undetectable.
Identifiants
pubmed: 33427619
pii: 15704
doi: 10.55563/clinexprheumatol/klc3h6
doi:
Substances chimiques
Anti-Citrullinated Protein Antibodies
0
Ligands
0
NK Cell Lectin-Like Receptor Subfamily K
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM